These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33234304)
1. Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva). Fix A; Kirkwood CD; Steele D; Flores J Vaccine; 2020 Dec; 38(52):8247-8254. PubMed ID: 33234304 [TBL] [Abstract][Full Text] [Related]
2. The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers. Chen J; Grow S; Iturriza-Gómara M; Hausdorff WP; Fix A; Kirkwood CD Viruses; 2022 Nov; 14(11):. PubMed ID: 36423174 [TBL] [Abstract][Full Text] [Related]
4. Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study. Debellut F; Pecenka C; Hausdorff WP; Clark A Hum Vaccin Immunother; 2022 Dec; 18(1):2040329. PubMed ID: 35240926 [TBL] [Abstract][Full Text] [Related]
5. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466 [TBL] [Abstract][Full Text] [Related]
7. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833 [TBL] [Abstract][Full Text] [Related]
9. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries. Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835 [TBL] [Abstract][Full Text] [Related]
10. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States. Rodriguez ZM; Goveia MG; Stek JE; Dallas MJ; Boslego JW; DiNubile MJ; Heaton PM Pediatr Infect Dis J; 2007 Mar; 26(3):221-7. PubMed ID: 17484218 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Clark A; van Zandvoort K; Flasche S; Sanderson C; Bines J; Tate J; Parashar U; Jit M Lancet Infect Dis; 2019 Jul; 19(7):717-727. PubMed ID: 31178289 [TBL] [Abstract][Full Text] [Related]
12. Measuring indirect effects of rotavirus vaccine in low income countries. Bennett A; Bar-Zeev N; Cunliffe NA Vaccine; 2016 Aug; 34(37):4351-3. PubMed ID: 27443593 [TBL] [Abstract][Full Text] [Related]
15. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. Patel MM; Parashar UD J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612 [TBL] [Abstract][Full Text] [Related]
16. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005. Wood D; Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525 [TBL] [Abstract][Full Text] [Related]
17. Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review. Ustrup M; Madsen LB; Bygbjerg IC; Konradsen F Dan Med Bull; 2011 Oct; 58(10):A4323. PubMed ID: 21975154 [TBL] [Abstract][Full Text] [Related]
18. Polio endgame: Lessons for the global rotavirus vaccination program. Jiang B; Patel M; Glass RI Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927 [TBL] [Abstract][Full Text] [Related]
19. Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden. Mahmud-Al-Rafat A; Muktadir A; Muktadir H; Karim M; Maheshwari A; Ahasan MM Infection; 2018 Feb; 46(1):15-24. PubMed ID: 29047020 [TBL] [Abstract][Full Text] [Related]
20. [Research progress in rotavirus VP4 subunit vaccine]. Jia L; Li T; Ge S Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1075-1084. PubMed ID: 28869727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]